000 | 01787 a2200541 4500 | ||
---|---|---|---|
005 | 20250515150043.0 | ||
264 | 0 | _c20090102 | |
008 | 200901s 0 0 eng d | ||
022 | _a1538-3652 | ||
024 | 7 |
_a10.1001/archderm.144.11.1520 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCooper, Susan M | |
245 | 0 | 0 |
_aVulvovaginal lichen planus treatment: a survey of current practices. _h[electronic resource] |
260 |
_bArchives of dermatology _cNov 2008 |
||
300 |
_a1520-1 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdministration, Topical |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aInternational Cooperation |
650 | 0 | 4 |
_aLichen Planus _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVaginal Diseases _xdiagnosis |
650 | 0 | 4 |
_aVulvar Diseases _xdiagnosis |
650 | 0 | 4 |
_aVulvovaginitis _xdiagnosis |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aHaefner, Hope K | |
700 | 1 | _aAbrahams-Gessel, Shafika | |
700 | 1 | _aMargesson, Lynette J | |
773 | 0 |
_tArchives of dermatology _gvol. 144 _gno. 11 _gp. 1520-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archderm.144.11.1520 _zAvailable from publisher's website |
999 |
_c18472423 _d18472423 |